Clinical trials expanding The success of GLP-1 agonists has validated peptides as a therapeutic class
Research models with chronic metabolic dysfunction often show NNMT overexpression that outpaces NAD+ synthesis capacity, creating a ceiling on how much metabolic improvement MOTS-c alone can produce
While peptides are generally considered safer than steroids, they can still have potential side effects like injection site reactions, allergic reactions, and changes in hormone levels
The right frequency depends on your individual needs, deficiency status, and treatment goals
Adv Funct Mater 31(22):2010882 Kuo H-C, Liu S-H, Lin Y-G, Chiang C-L, Tsang DC (2020) Synthesis of FeCoN@ N-doped carbon oxygen reduction catalysts via microwave-assisted ammoxidation
5Amino1MQ (5Amino1Methylquinolinium) is a novel small molecule derived from quinolinium salts that has been studied for its ability to inhibit NNMT (Nicotinamide NMethyltransferase), an enzyme involved in metabolic dysfunction, obesity, and cellular aging